Connection
Mary Weiser-Evans to Metformin
This is a "connection" page, showing publications Mary Weiser-Evans has written about Metformin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.194 |
|
|
|
-
McNair BD, Polson SM, Shorthill SK, Yusifov A, Walker LA, Weiser-Evans MCM, Kovacs EJ, Bruns DR. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK. Am J Physiol Heart Circ Physiol. 2023 08 01; 325(2):H278-H292.
Score: 0.171
-
Roe ND, Xu X, Kandadi MR, Hu N, Pang J, Weiser-Evans MC, Ren J. Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy. Biochim Biophys Acta. 2015 Feb; 1852(2):290-8.
Score: 0.023